Hem › Steatotisk leversjukdom › Kalifornien
Kliniska studier för Steatotisk leversjukdom i Kalifornien
22 studier för Steatotisk leversjukdom söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
- San Diego14 studier
- Pasadena8 studier
- Los Angeles8 studier
- Lancaster7 studier
- Orange5 studier
- San Francisco5 studier
- Huntington Beach5 studier
- Fresno5 studier
- Rialto5 studier
- Long Beach4 studier
- Folsom4 studier
- Escondido3 studier
- Sacramento3 studier
- Santa Maria3 studier
- Simi Valley3 studier
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Camarillo
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- och 10 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 89bio Clinical Study Site, Escondido
- och 13 fler
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06318169A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Folsom
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Southern California Research Center, Coronado
- California Liver Research Institute, Pasadena
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of California San Diego NAFLD Research Center, La Jolla
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
- och 2 fler
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Southern California Research Center, Coronado
- Om Research Llc, Lancaster
- Clinnova Research Solutions, Orange
- och 3 fler
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- San Fernando Valley Health Institute, Canoga Park
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Fresno Clinical Research Center, Fresno
- och 11 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Coronado
- Akero Clinical Study Site, Escondido
- Akero Clinical Study Site, Folsom
- och 13 fler
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Los Angeles
- och 3 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Om Research, Apple Valley
- ARK Clinical Research - Fountain Valley, Fountain Valley
- UCSD Medical Center, La Jolla
- och 4 fler
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 9 sep. 2026 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Coronado
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Los Angeles
- och 3 fler
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Arcadia
- GSK Investigational Site, Covina
- GSK Investigational Site, Folsom
- och 6 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 27 juli 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Fresno
- GSK Investigational Site, Lancaster
- GSK Investigational Site, Pasadena
- och 2 fler
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 8 juli 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Rialto
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 9 juni 2026 · NCT07358546Bicalutamide Therapy in Young Women With NAFLD and PCOS
- University of California San Francisco, San Francisco
RekryterarFas 1
Ålder 18 till 42 · Kvinnor · Uppdaterad 29 maj 2026 · NCT05979389A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Velocity Clinical research, Los Angeles
RekryterarFas 1/2Friska volontärer välkomna
Ålder 18 till 75 · Alla kön · Uppdaterad 16 apr. 2026 · NCT05648214Androgens and NAFLD Longitudinal Cohort Study
- University of California San Francisco, San Francisco
RekryterarObservationsstudie
Ålder 18 till 42 · Kvinnor · Uppdaterad 13 apr. 2026 · NCT06124261Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- University of California San Diego, La Jolla
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT07518784Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
- University of California San Diego, La Jolla
RekryterarObservationsstudie
Ålder 9 till 18 · Alla kön · Uppdaterad 21 jan. 2026 · NCT06706856Implementing Food Referrals for Equity and Sustained Health
- Rady Children's Hospital San Diego, San Diego
RekryterarFas 2Friska volontärer välkomna
Ålder 5 och äldre · Alla kön · Uppdaterad 19 nov. 2025 · NCT06661538Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
RekryterarFriska volontärer välkomna
Ålder 35 till 65 · Alla kön · Uppdaterad 4 dec. 2024 · NCT05165706Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.